Perlegen Sciences, Inc. Introduces BREVAGen Breast Cancer Risk Stratification Test
9/24/2009 7:15:39 AM
More...
|
Perlegen Sciences, Inc. Introduces BREVAGen(TM) Breast Cancer Risk Stratification Test
9/23/2009 11:34:25 AM
More...
|
Perlegen Sciences, Inc. Receives CLIA License
6/5/2009 9:34:46 AM
More...
|
Perlegen Sciences, Inc. Builds Commercial Group to Support Upcoming MammaPLUS(TM) Launch
4/28/2009 11:51:38 AM
More...
|
Perlegen Sciences, Inc. Out-Licenses Genetic Diagnostics Intellectual Property to Celera Corporation (CRA)
4/23/2009 10:17:42 AM
More...
|
Perlegen Sciences, Inc. Launches New Approach to Detect Rare Genetic Variants
9/16/2008 2:49:38 PM
More...
|
Perlegen Sciences, Inc. Out-Licenses Intellectual Property for Genetic Diagnostics
7/15/2008 6:28:10 AM
More...
|
Perlegen Sciences, Inc. Gains Exclusive Access to Data on Four Million Patients to Enable Personalized Medicine
3/18/2008 10:12:52 AM
More...
|
Perlegen Sciences, Inc. and SC Liver Research Consortium to Collaborate on Interferon Response in Hepatitis C Patients
2/19/2008 8:36:56 AM
More...
|
Perlegen Sciences, Inc. Fills out Leadership Team to Prepare for Multiple Personalized Medicine Programs
2/14/2008 8:33:04 AM
More...
|
|